For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Munich D-81675

0 studies enrolling now · 13 studies all time

What they study most

Alzheimer's Disease, Colorectal Cancer, Coronary Artery Disease (CAD), Lymphoma, Follicular, Major Depressive Disorder, Muscular Dystrophy, Duchenne, Neoplasm Metastasis, Neoplasms, Pancreatic Cancer, Rheumatoid Arthritis, Sepsis

Studies at this site

• Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer — Completed
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• A Study of Tadalafil for Duchenne Muscular Dystrophy — Stopped early
• Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease — Stopped early
• A Study in Second Line Metastatic Colorectal Cancer — Completed
• A Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of Enzastaurin in Participants With Follicular Lymphoma — Completed
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer — Completed
• A Study in Participants With Rheumatoid Arthritis — Stopped early
• A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor — Completed
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock — Completed
• Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) — Stopped early